Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma

9 Dec 2014

Abstract excerpt

// Ye Yang 1, * , Wen Zhou 1, * , Jiliang Xia 1 , Zhimin Gu 1 , Erik Wendlandt 1 , Xin Zhan 2 , Siegfried Janz 3 , Guido Tricot 1 , Fenghuang Zhan 1 1 Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, United States 2 Vanderbilt University, Nashville, Tennessee, United States 3 Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, United States...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to Multiple Myeloma Research and Treatments
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25230277
DOI: 10.18632/oncotarget.2388

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NEK2 mediates ALDH1A1-dependent drug resistance in multiple myelomaPMID 25230277Read ↗

Chromosomal instability and acquired drug resistance in multiple myelomaSemantic proximity Read ↗

Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanismsSemantic proximity Read ↗

Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic ModificationsSemantic proximity Read ↗

ABL1 Kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myelomaSemantic proximity Read ↗

Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?Semantic proximity Read ↗

Novel Pan-ALDH Inhibitor KS100 Effectively Targets ALDH+/CD138⁻ Stem-like Cells to Overcome Relapse in Multiple MyelomaSemantic proximity Read ↗

EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functionsSemantic proximity Read ↗

Kinome expression profiling to target new therapeutic avenues in multiple myelomaSemantic proximity Read ↗

Role of micro-RNAs in drug resistance of multiple myelomaSemantic proximity Read ↗

Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple MyelomaSemantic proximity Read ↗

LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a/MCL1 pathway.Semantic proximity Read ↗

Gene expression profiling defines a high-risk entity of multiple myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.